e.l.f. Beauty's Skin Care Mix Reaches 23%, but Valuation and Tariff Risks Persist

What happened

The article highlights that e.l.f. Beauty's skin care portfolio now accounts for 23% of global consumption, driven by e.l.f. SKIN, Naturium, and rhode, signaling an increasing strategic shift toward higher-margin skin care. This aligns with management's pivot to a multi-brand portfolio, but the DeepValue report underscores that the core e.l.f. brand's organic growth remains anemic at ~3-4% ex-Rhode, and the company faces significant headwinds from elevated China tariffs compressing gross margins. Despite the skin care mix improvement, FY26 guidance shows flat adjusted EBITDA and declining net income, as higher marketing spend and debt servicing costs from the Rhode acquisition dilute earnings. The stock still trades at ~64x trailing EPS and ~28x EV/EBITDA, implying expectations for a rapid return to mid-teens growth that seem optimistic given tariff and competitive pressures. The skin care expansion is a positive operational development but does not materially alter the risk-reward profile, which remains skewed to the downside absent a significant price reset or clear evidence of organic re-acceleration.

Implication

The increase in skin care mix to 23% validates e.l.f.'s strategy of moving into higher-margin segments, but this is already factored into the narrative and does little to alleviate the core concerns around tariffs and organic growth. With ex-Rhode organic growth stuck in low single digits and gross margin under pressure from ~60% China tariffs, the skin care shift alone cannot bridge the gap to the elevated expectations embedded in the stock’s valuation. The Rhode acquisition, while contributing to skin care scale, adds leverage and interest costs that further compress net income, as seen in the FY26 guidance. Investors should monitor whether the skin care mix can materially lift overall gross margins above 70% in a sustained way, and whether core e.l.f. brand growth re-accelerates beyond 5% in FY27. Until these conditions are met or the stock price corrects toward our attractive entry of $65, maintaining a cautious stance with potential to trim on any strength is prudent.

Thesis delta

The article confirms that e.l.f.'s skin care portfolio is gaining share and now represents a larger portion of consumption, which is operationally positive. However, this does not shift the bearish thesis from the DeepValue report, which centers on valuation and tariff risk. The skin care growth provides a modest offset but is insufficient to warrant a change in rating or conviction.